Showing results (1011-1020 of 1,163) with videos related to
Sort By:
Pageof 117
Circulation|June 9, 2020
Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual WorkshopSana M Al-Khatib, Emelia J Benjamin, Christine M Albert, et al.Circulation. Heart Failure|August 27, 2022
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER TrialAlexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, et al.The Lancet. Respiratory Medicine|February 26, 2023
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trialsAhmet Z Uluer, Gordon MacGregor, Pilar Azevedo, et al.European Journal of Heart Failure|June 26, 2024
Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fractionMingming Yang, Toru Kondo, Pardeep S Jhund, et al.Circulation. Cardiovascular Imaging|February 12, 2026
Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial IntelligenceAdam Ioannou, Michel G Khouri, Takeshi Kitai, et al.European Journal of Heart Failure|February 5, 2024
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approachBart J van Essen, Ganash N Tharshana, Wouter Ouwerkerk, et al.Journal of the American College of Cardiology|August 27, 2023
Dapagliflozin in Patients With Heart Failure and Deterioration in Renal FunctionSafia Chatur, Muthiah Vaduganathan, Brian L Claggett, et al.ESC Heart Failure|February 19, 2026
The impact of country income level on the management of heart failure with preserved ejection fraction: an international surveyInga J Ingimarsdóttir, Clara Saldarriaga, Niels C R Nielsen, et al.Journal of the American College of Cardiology|January 15, 2025
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HFShingo Matsumoto, Pardeep S Jhund, Alasdair D Henderson, et al.JAMA Cardiology|November 17, 2024
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialMisato Chimura, Xiaowen Wang, Pardeep S Jhund, et al.Pageof 117